Imaging visualizes rheumatoid arthritis inflammation in preclinical study.
Use of PET and SPECT imaging allowed researchers to visualize inflamed synovial tissue in mice, as well as the uptake correlated with the severity of the inflammation, according to a study presented at the Society of Nuclear Medicine and Molecular Imaging 2014 annual meeting.
Dutch researchers performed the preclinical study using PET and SPECT to evaluate antifibroblast activation protein (FAP) antibodies, which are involved in rheumatoid arthritis (RA) inflammation. Radiotracers labeled with 89Zr and 111In for specific imaging of FAP expression in an experimental model of RA were used.
The results showed that both 89Zr-28H1 and 111In-28H1 showed high uptake in the inflamed joints. This was three to four times higher than that of the irrelevant isotype-matched control antibody DP47GS.
“Uptake of 111In-28H1 ranged from 3.3 percent ID/g in non-inflamed joints to 27.4 percent ID/g in severely inflamed joints,” the authors wrote. “DP47GS accumulation ranged from 2.5 percent ID/g in non-inflamed tissue to 11.7 percent ID/g in severely inflamed joints.” The uptake of 28H1 in inflamed joints correlated with arthritis score and increased with severity of inflammation.
The researchers concluded that the “anti-FAP antibody 28H1 labeled with 89Zr or 111In showed excellent characteristics for imaging inflamed synovial tissue, and uptake correlated with severity of the inflammation.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.